Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.24
0.3518.52%
At close: -
$2.18
-0.06-2.68%
After Hours: 7:54 PM EDT
Comments
Loading...
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Humacyte Stock Price, Quotes and Forecasts | NASDAQ:HUMA | Benzinga
Explore Humacyte stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HUMA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Humacyte (HUMA) stock?
You can purchase shares of Humacyte (NASDAQ:HUMA) through any online brokerage.
Who are Humacyte (HUMA) competitors?
Other companies in Humacyte’s space includes: Monopar Therapeutics (NASDAQ:MNPR), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA), Neurogene (NASDAQ:NGNE) and Abeona Therapeutics (NASDAQ:ABEO).
What is the forecast, or price target, for Humacyte (HUMA) stock?
Humacyte has a consensus price target of $12.30.
What is the current price for Humacyte (HUMA)?
The stock price for Humacyte (NASDAQ: HUMA) is $2.1799 last updated May 16, 2025 at 7:54 PM EDT.
Does Humacyte (HUMA) pay a dividend?
There are no upcoming dividends for Humacyte.
When is Humacyte (NASDAQ:HUMA) reporting earnings?
Humacyte’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
Is Humacyte (HUMA) going to split?
There is no upcoming split for Humacyte.
What sector and industry does Humacyte (HUMA) operate in?
Humacyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
